Nur 1141 EXAM4 STUDY GUIDE
NUR1141 EXAM REVISION QUESTION
CORRECTLY ANSWERED
compliance - ANS implementation or fulfillment of a prescriber's or care givers
prescribed course of treatment or therapeutic plan by a patient
medication error - ANS Any preventable adverse drug event involving inappropriate
medication use by a patient or health care professional; it may or may not cause the
patient harm.
Noncompliance - ANS An informed decision on the part of the patient not to adhere to
or follow a therapeutic plan or suggestion.
nursing process - ANS an organized framework for the practice of nursing, it
encompasses all the steps taken by the nurse in caring for a patient Assessment
Diagnosis
Planning
Implementation
Evaluation
outcomes - ANS descriptions of specific patient behaviors or responses that
demonstrate meeting of or achievement of behaviors related to each nursing diagnosis.
these statements are specific while framed in behavioral terms and are measurable.
prescriber - ANS Any health care professional licensed by the appropriate regulatory
board to prescribe medications.
Adverse effects - ANS A general term for any undesirable effects that are a direct
response to one or more drugs.
Agonist - ANS a drug that binds to and stimulates the activity of one or more receptors
in the body
allergic reaction - ANS An immunologic hypersensitivity reaction resulting from the
unusual sensitivity of a patient to a particular medication; a type of adverse drug event.
, Antagonist - ANS drug that binds to and inhibits the activity of one or more receptors in
the body; also called inhibitors
chemical name - ANS The name that describes the chemical composition and
molecular structure of a drug.
contraindication - ANS A reason why something is not advisable or why it should not
be done.. any condition, especially one related to a disease state or patient
characteristic, including current or recent drug therapy, which renders a particular form
of treatment improper or undesirable
drug - ANS any chemical that affects the physiologic process of a living organism.
Drug classification - ANS A method of grouping drugs; may be based on structure or
therapeutic use.
generic - ANS name give by the united states adopted names council. also called the
non proprietary name. generic name much shorter and simpler than the chemical name
and is not protected by trademark.
half-life - ANS pharmacokinetics, the time required for half of the drug to be eliminated
by the body, or the time it takes for the blood level of a drug to be reduced by 50%
peak level - ANS The maximum concentration of a drug in the body after
administration, usually measured in a blood sample for therapeutic drug monitoring.
pharmaceutics - ANS the science of preparing and dispensing drugs, including dosage
form design
receptor - ANS a molecular structure within or on the outer surface of a cell. they bind
to specific substances and one or more corresponding cellular effects (drug actions)
occur as a result of this drug-receptor interaction.
therapeutic drug monitoring - ANS process of measuring drug levels to identify a
patients drug exposure and to allow adjustment of dosages with the goals of maximizing
therapeutic effects and minimizing toxicity
trade name - ANS a commercial name given to a drug product by its manufacturer;
also called the proprietary name
NUR1141 EXAM REVISION QUESTION
CORRECTLY ANSWERED
compliance - ANS implementation or fulfillment of a prescriber's or care givers
prescribed course of treatment or therapeutic plan by a patient
medication error - ANS Any preventable adverse drug event involving inappropriate
medication use by a patient or health care professional; it may or may not cause the
patient harm.
Noncompliance - ANS An informed decision on the part of the patient not to adhere to
or follow a therapeutic plan or suggestion.
nursing process - ANS an organized framework for the practice of nursing, it
encompasses all the steps taken by the nurse in caring for a patient Assessment
Diagnosis
Planning
Implementation
Evaluation
outcomes - ANS descriptions of specific patient behaviors or responses that
demonstrate meeting of or achievement of behaviors related to each nursing diagnosis.
these statements are specific while framed in behavioral terms and are measurable.
prescriber - ANS Any health care professional licensed by the appropriate regulatory
board to prescribe medications.
Adverse effects - ANS A general term for any undesirable effects that are a direct
response to one or more drugs.
Agonist - ANS a drug that binds to and stimulates the activity of one or more receptors
in the body
allergic reaction - ANS An immunologic hypersensitivity reaction resulting from the
unusual sensitivity of a patient to a particular medication; a type of adverse drug event.
, Antagonist - ANS drug that binds to and inhibits the activity of one or more receptors in
the body; also called inhibitors
chemical name - ANS The name that describes the chemical composition and
molecular structure of a drug.
contraindication - ANS A reason why something is not advisable or why it should not
be done.. any condition, especially one related to a disease state or patient
characteristic, including current or recent drug therapy, which renders a particular form
of treatment improper or undesirable
drug - ANS any chemical that affects the physiologic process of a living organism.
Drug classification - ANS A method of grouping drugs; may be based on structure or
therapeutic use.
generic - ANS name give by the united states adopted names council. also called the
non proprietary name. generic name much shorter and simpler than the chemical name
and is not protected by trademark.
half-life - ANS pharmacokinetics, the time required for half of the drug to be eliminated
by the body, or the time it takes for the blood level of a drug to be reduced by 50%
peak level - ANS The maximum concentration of a drug in the body after
administration, usually measured in a blood sample for therapeutic drug monitoring.
pharmaceutics - ANS the science of preparing and dispensing drugs, including dosage
form design
receptor - ANS a molecular structure within or on the outer surface of a cell. they bind
to specific substances and one or more corresponding cellular effects (drug actions)
occur as a result of this drug-receptor interaction.
therapeutic drug monitoring - ANS process of measuring drug levels to identify a
patients drug exposure and to allow adjustment of dosages with the goals of maximizing
therapeutic effects and minimizing toxicity
trade name - ANS a commercial name given to a drug product by its manufacturer;
also called the proprietary name
